Sort
85,873 grants matching “alzheimers”
The regulation of synaptic transmission and neural circuit function
$808,811Wei Lu · National Institute Of Neurological Disorders And Stroke · ZIA · FY2012 · NS
Measuring Caregiver Networks of Older Adults with Alzheimer's Disease
$808,808Lee A Lindquist · Northwestern University At Chicago · R01 · FY2023 · AG
Molecular Chemiluminescence Probes for Imaging of Amyloid beta in Animal Models
$808,786Chongzhao Ran · Massachusetts General Hospital · R01 · FY2025 · AG
Informing optimal first-line antihypertensive therapy: A rigorous comparative effectiveness analysis of ARBs vs. ACEIs on long-term risk of dementia, cancer, heart disease, and quality of life
$808,711Jordana B. Cohen · University Of Pennsylvania · R01 · FY2022 · AG
Concurrent Aerobic Exercise and Cognitive Training to Prevent Alzheimer's in at-risk Older Adults
$808,635Olu Olofinboba · Moai Technologies, Llc · R44 · FY2024 · AG
Social Convoys, Cognitive Reserve and Resilience, and Risk for Alzheimer's Disease and Related Dementias
$808,619Walter O. Bockting · New York State Psychiatric Institute Dba Research Foundation For Mental Hygiene, Inc · R01 · FY2020 · AG
Clinical Core
$808,599Teresa Gomez-Isla · Massachusetts General Hospital · P30 · FY2023 · AG
Clinical Core
$808,599Teresa Gomez-Isla · Massachusetts General Hospital · P30 · FY2019 · AG
Clinical Core
$808,599Teresa Gomez-Isla · Massachusetts General Hospital · P30 · FY2022 · AG
A brain multi-omic approach to identify key molecular drivers of neuropsychiatric symptoms in Alzheimer's dementia
$808,578Aliza Pham Wingo · Emory University · R01 · FY2022 · AG
Multicenter Study on Exceptional Survival in Families
$808,511Richard Mayeux · Columbia University Health Sciences · U01 · FY2008 · AG
Identifying and supporting patients with undiagnosed dementia using the EHR Risk of Alzheimer's and Dementia Assessment Rule (eRADAR): a pilot clinical trial
$808,490Sascha Dublin · Kaiser Foundation Research Institute · R01 · FY2020 · AG
Clinical Core
$808,433Alan J Lerner · Cleveland Clinic Lerner Com-Cwru · P30 · FY2020 · AG
Mechanistic clinical trial evaluating the role of the metabotropic glutamate receptor subtype 5 (mGluR5) in the antidepressant mechanism of Cognitive Behavioral Therapy for Insomnia (CBT-I)
$808,417Christine Delorenzo · State University New York Stony Brook · R01 · FY2025 · MH
Gamma Secretase Assays to Discover Drugs for Alzheimer's
$808,397Gregory R Hook · American Life Science Pharmaceuticals · R44 · FY2006 · AG
Predictors of Severity in Alzheimer's Disease
$808,304Yaakov Stern · Columbia University Health Sciences · R01 · FY2007 · AG
Transcranial Photobiomodulation for Alzheimer's Disease (TRAP-AD)
$808,272Dan Vlad Iosifescu · New York University School Of Medicine · R01 · FY2024 · AG
Transcranial Photobiomodulation for Alzheimer's Disease (TRAP-AD)
$808,272Dan Vlad Iosifescu · New York University School Of Medicine · R01 · FY2023 · AG
UPLIFT-AD (Utilizing Palliative Leaders in Facilities to Transform care for Alzheimer's Disease) intervention
$808,236Kathleen T Unroe · Indiana University Indianapolis · R01 · FY2020 · AG
Glutathione, Brain Metabolism and Inflammation in Alzheimer's Disease
$808,231Rajagopal Viswanath Sekhar · Baylor College Of Medicine · R01 · FY2020 · AG
Biology of Prion Protein and the TSE Diseases
$808,228Bruce Chesebro · National Institute Of Allergy And Infectious Diseases · ZIA · FY2025 · AI
Evaluation of a novel NLK function in lysosome biogenesis and neurodegenerative diseases
$808,198Janghoo Lim · Yale University · R01 · FY2023 · AG
Evaluation of a novel NLK function in lysosome biogenesis and neurodegenerative diseases
$808,198Janghoo Lim · Yale University · R01 · FY2021 · AG
Evaluation of a novel NLK function in lysosome biogenesis and neurodegenerative diseases
$808,198Janghoo Lim · Yale University · R01 · FY2024 · AG
Evaluation of a novel NLK function in lysosome biogenesis and neurodegenerative diseases
$808,198Janghoo Lim · Yale University · R01 · FY2022 · AG